TEVA GRABS 20% MARKET SHARE OF ZOLOFT IN A WEEK

Within a week of launching its generic version, Teva has achieved a 20% share of the Zoloft market. Specifically, Teva's version accounted for 19.7% of last week' sales of the antidepressant originally made by Pfizer, according to IMS. Haaretz (http://www.haaretz.com/hasen/spages/756601.html)